Related Experiment Videos
Reactive oxygen species in vascular wall
Lai Ming Yung1, Fung Ping Leung, Xiaoqiang Yao
1Department of Physiology, Chinese University of Hong Kong, Shatin, NT, Hong Kong SAR, China.
Summary
Reactive oxygen species (ROS) cause cardiovascular diseases like hypertension and atherosclerosis by overwhelming the body's antioxidant defenses. Understanding ROS signaling in vascular cells is key to developing treatments for these oxidative stress-related disorders.
Area of Science:
- Cardiovascular Biology
- Oxidative Stress Research
- Molecular Medicine
Background:
- Reactive oxygen species (ROS) are key contributors to cardiovascular diseases, including hypertension, atherosclerosis, cardiac hypertrophy, heart failure, and diabetes mellitus.
- Oxidative stress arises when excessive ROS generation overwhelms endogenous antioxidant systems.
- Vascular cells are primary targets of ROS, affecting critical signaling pathways and cellular functions.
Purpose of the Study:
- To elucidate the role of ROS signaling in vascular cells.
- To discuss the mechanisms by which oxidative stress induces vascular damage.
- To explore therapeutic strategies for ROS-associated cardiovascular disorders.
Main Methods:
- Review of literature on ROS biology and cardiovascular pathology.
- Analysis of oxidant and antioxidant enzyme modulation in disease states.
- Examination of ROS effects on vascular cell signaling and function.
Main Results:
- ROS impair vascular function by reducing nitric oxide bioavailability, hindering vasodilation, and promoting endothelial cell dysfunction.
- Oxidative stress contributes to vascular remodeling through apoptosis, altered cell migration, and inflammation.
- Dysregulated ROS signaling impacts vascular smooth muscle cell growth, migration, and inflammatory responses.
Conclusions:
- ROS signaling plays a critical role in the pathogenesis of diverse cardiovascular diseases.
- Oxidative stress-induced vascular damage is a central mechanism in the progression of hypertension and atherosclerosis.
- Targeting ROS pathways presents a promising therapeutic avenue for cardiovascular disorders.